# A Drug Interaction Study of Albiglutide and Digoxin

> **NCT01147718** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 30 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **BIOLOGICAL:** digoxin plus albiglutide

## Key facts

- **NCT ID:** NCT01147718
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-11
- **Primary completion:** 2010-11-29
- **Final completion:** 2010-11-29
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147718, "A Drug Interaction Study of Albiglutide and Digoxin". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01147718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*